Skip to main content
. 2003 Jan 15;31(2):e3. doi: 10.1093/nar/gng003

Table 1. Telomerase activity in human hepatocytes and hepatoma cell lines.

Cells TRAP-ELISAa RQ-TRAP TRAPezeb
Human hepatocytes
Fetal-04/00 0.3 ± 0.16 (n = 4) 0.5 ± 0.14 (n = 4) + (n = 2)
Fetal-10/01 0.9 ± 0.53 (n = 4) 1.1 ± 0.30 (n = 4) + (n = 2)
Pediatric-11/01 0.2 ± 0.15 (n = 2) 1.2 ± 0.11 (n = 4) + (n = 2)
Pediatric-27/01 0.0 ± 0.01 (n = 2) 1.8 ± 0.15 (n = 4) + (n = 2)
Pediatric-13/01 0.0 ± 0.00 (n = 2) 1.7 ± 0.15 (n = 2) + (n = 2)
Pediatric-26/02 0.0 ± 0.00 (n = 4) 0.4 ± 0.10 (n = 2) + (n = 2)
Adult-23/00 1.0 ± 0.85 (n = 2) 1.0 ± 0.38 (n = 4) + (n = 2)
Adult-09/01 0.2 ± 0.10 (n = 2) 0.8 ± 0.09 (n = 4) + (n = 2)
Hepatoma cell lines
Hep G2 51.2 ± 3.40 (n = 4) 57.4 ± 3.63 (n = 8) ND
HLE 35.5 ± 8.11 (n = 4) 22.7 ± 1.02 (n = 6) ND
HLF 40.3 ± 7.57 (n = 4) 36.8 ± 2.81 (n = 6) ND
HuH 7 44.3 ± 6.75 (n = 4) 37.3 ± 0.43 (n = 6) ND

All values are expressed as means ± SEM of the indicated number of measurements. Telomerase activity is tabulated as RTA per 1000 cells. ND, not determined.

aThe quantitative TeloTAGGG Telomerase PCR ELISAPLUS was employed to quantitate telomerase activity.

bLow RQ-TRAP results were confirmed with the qualitative TRAPeze ELISA Telomerase Detection Kit.